Terms: = Lymphoma AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
399 results:
1. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia.
Yang T; Gou H; Lin T; Yang Y; Jin X; Dong T; Zhang Y; Chen X
Int J Pharm; 2024 Apr; 654():123971. PubMed ID: 38452832
[TBL] [Abstract] [Full Text] [Related]
2. Neutrophilic Dermatosis of the Hands: A Case Report.
Yaghoobi R; Bagherani N; R Smoller B; Pazyar N
Acta Dermatovenerol Croat; 2023 Dec; 31(3):148-50. PubMed ID: 38439725
[TBL] [Abstract] [Full Text] [Related]
3. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Characteristics And treatment Outcome Of Paediatric Non-Hodgkin's lymphoma At A Tertiary Care Hospital In Pakistan.
Naqvi J; Sajid MI; Khan S; Nisa Kamran ZU; Fadoo Z
J Pak Med Assoc; 2023 Nov; 73(11):2161-2164. PubMed ID: 38013521
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer.
Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
[TBL] [Abstract] [Full Text] [Related]
6. Study of anticancer effects of platinum levetiracetam and levetiracetam via cancer biomarkers genes expression on HepG2 cell line.
Sabokrouh A; Sadeghi Motlagh B; Atabi F
Mol Biol Rep; 2023 Nov; 50(11):9431-9439. PubMed ID: 37831345
[TBL] [Abstract] [Full Text] [Related]
7. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
8. Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL.
Tam C; Pinilla-Ibarz J; Castillo CG; Fenili AC; Huntley K; Karakus V; Mattar M; Miroli MA; Moura C; Pavlovsky M; Piotrowski F; Šimkovič M; Stilgenbauer S
Blood Adv; 2023 Nov; 7(22):6819-6828. PubMed ID: 37722356
[TBL] [Abstract] [Full Text] [Related]
9. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract] [Full Text] [Related]
10. Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with
Duarte A; Montagna DR; Pastorini M; Alemán M
Front Immunol; 2023; 14():1176432. PubMed ID: 37377961
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B-ALL in CR1 with no detectable minimal residual disease.
Lv M; Liu L; He Y; Yang D; Ma Q; Pang A; Zhai W; Wei J; Huang Y; Chen X; Zhang G; Feng S; Han M; Jiang E; Zhang R
Br J Haematol; 2023 Jul; 202(2):369-378. PubMed ID: 37157187
[TBL] [Abstract] [Full Text] [Related]
13. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract] [Full Text] [Related]
14. Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal treatment of Vitreoretinal lymphoma With Methotrexate.
Gu J; Jiang T; Liu S; Chen X; Wang Z; Zhang P; Wang L; Jiang R; Huang X; Xu G; Chang Q
Am J Ophthalmol; 2023 Jul; 251():189-196. PubMed ID: 36963600
[TBL] [Abstract] [Full Text] [Related]
15. The Oral PI3Kδ Inhibitor Linperlisib for the treatment of Relapsed and/or Refractory Follicular lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.
Wang T; Sun X; Qiu L; Su H; Cao J; Li Z; Song Y; Zhang L; Li D; Wu H; Zhang W; Li J; Zhou K; Zhou H; Yang Y; Li Z; Cen H; Cai Z; Zhang Z; Fu W; Jin J; Li F; Wu W; Gu X; Zhu W; Liu L; Li Z; Yi S; Bao H; Xu Z; Qiu L
Clin Cancer Res; 2023 Apr; 29(8):1440-1449. PubMed ID: 36735519
[TBL] [Abstract] [Full Text] [Related]
16. Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center.
Chacim S; Monjardino T; Cunha JL; Medeiros P; Redondo P; Bento MJ; Mariz JM
PLoS One; 2022; 17(12):e0278950. PubMed ID: 36490296
[TBL] [Abstract] [Full Text] [Related]
17. Detection and evolutionary dynamics of somatic fas variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.
Batlle-Masó L; Garcia-Prat M; Parra-Martínez A; Franco-Jarava C; Aguiló-Cucurull A; Velasco P; Antolín M; Rivière JG; Martín-Nalda A; Soler-Palacín P; Martínez-Gallo M; Colobran R
Front Immunol; 2022; 13():1014984. PubMed ID: 36466883
[TBL] [Abstract] [Full Text] [Related]
18. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine.
Wong SHM; Fang CM; Loh HS; Ngai SC
Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402
[TBL] [Abstract] [Full Text] [Related]
19. Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.
Rokan A; Hernandez JC; Nitiyanandan R; Lin ZY; Chen CL; Machida T; Li M; Khanuja J; Chen ML; Tahara SM; Siddiqi I; Machida K
Mol Cancer Res; 2023 Feb; 21(2):155-169. PubMed ID: 36287175
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera
Shi Y; Zhang Q; Hong X; Wang Z; Gao Y; Zou L; Cen H; Gui L; Li Y; Feng J; Wang Z; Zhang M; Jin C; Zhang W; Hu J; Zheng C; Zheng Z; Zhang L; Chen S; Huang Y; Tang Y; Gao Y; Hao M; Li X; Chang C; Yang H; Wu H; Shen L; Ke X; Zhang L; Xi Y; Yang L; Xie L; Gai W; Ji Y
Hematol Oncol; 2022 Dec; 40(5):930-940. PubMed ID: 35858181
[TBL] [Abstract] [Full Text] [Related]
[Next]
